Abcam Signs License Agreement with Pfizer
Wednesday, June 12, 2013
Company to supply a range of authentic Pfizer compounds to researchers.
Big Multiple Sclerosis Breakthrough
Tuesday, June 11, 2013
Phase 1 trial safely resets patients’ immune systems, reduces attack on myelin protein.
BACH2 Helps Orchestrate the Immune Response
Tuesday, June 11, 2013
A gene called BACH2 may affect the development of MS, asthma, Crohn's disease, celiac disease and other allergic and autoimmune diseases.
ExpreS2ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement
Tuesday, June 11, 2013
ExpreS2ion Biotechnologies will provide the Cancer Research UK with access to its Drosophila Schneider-2 cell-based technology platform for protein production.
TB Bacteria's Trash-Eating Inspires Search for New Drugs
Tuesday, June 11, 2013
When hijacking a garbage truck, one might as well make use of the trash. That logic drives how tuberculosis-causing bacteria feed, say Cornell scientists.
Identified a Key Protein in Maintaining the Identity of B Lymphocytes
Monday, June 10, 2013
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.
Promising Drug Prevents Cancer Cells from Shutting Down Immune System
Monday, June 10, 2013
An investigational drug that targets the immune system’s ability to fight cancer is showing promising results in Yale Cancer Center (YCC) patients.
Combined Immunotherapy Shows Promising Results Against Advanced Melanoma
Monday, June 10, 2013
Combining two cancer immunotherapy drugs in patients with advanced melanoma produced rates of tumor regression that appeared greater than in prior trials with either drug alone.
SentoClone Significantly Strengthens its Global Patent Portfolio
Friday, June 07, 2013
New patents granted in Japan, the USA and Europe.
|
|
|
|
|
|
